251 related articles for article (PubMed ID: 21435303)
1. Access to life-saving medicines and intellectual property rights: an ethical assessment.
Schroeder D; Singer P
Camb Q Healthc Ethics; 2011 Apr; 20(2):279-89. PubMed ID: 21435303
[No Abstract] [Full Text] [Related]
2. Introduction: Access to life-saving medicines and intellectual property rights.
Schroeder D
Camb Q Healthc Ethics; 2011 Apr; 20(2):277-8. PubMed ID: 21435302
[No Abstract] [Full Text] [Related]
3. Does the pharmaceutical sector have a coresponsibility for the human right to health?
Schroeder D
Camb Q Healthc Ethics; 2011 Apr; 20(2):298-308. PubMed ID: 21435305
[No Abstract] [Full Text] [Related]
4. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
5. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
6. [Inequalities of access to care and in participation in research on a worldwide level: ethical problems].
France. Comite consultatif national d'ethique pour les sciences de la vie et de la sante
J Int Bioethique; 2005; 16(3-4):152-3. PubMed ID: 17058809
[No Abstract] [Full Text] [Related]
7. Patents and access to drugs in developing countries: an ethical analysis.
Sterckx S
Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
[TBL] [Abstract][Full Text] [Related]
8. Access to essential medicines: a Hobbesian social contract approach.
Ashcroft RE
Dev World Bioeth; 2005 May; 5(2):121-41. PubMed ID: 15842722
[TBL] [Abstract][Full Text] [Related]
9. Developing medicines in line with global public health needs: the role of the World Health Organization.
Pang T
Camb Q Healthc Ethics; 2011 Apr; 20(2):290-7. PubMed ID: 21435304
[No Abstract] [Full Text] [Related]
10. Access to essential drugs, human rights and global justice.
Shalev C
Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
[No Abstract] [Full Text] [Related]
11. The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.
Cohen JC; Illingworth P
Dev World Bioeth; 2003 May; 3(1):27-48. PubMed ID: 14577451
[TBL] [Abstract][Full Text] [Related]
12. [Intellectual property rights and right of access to medicines].
Velásquez G
Med Trop (Mars); 2006 Dec; 66(6):526-8. PubMed ID: 17286013
[TBL] [Abstract][Full Text] [Related]
13. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
Rosina MS; Shaver L
J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
[TBL] [Abstract][Full Text] [Related]
14. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
Resnik DB; DeVille KA
Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
[No Abstract] [Full Text] [Related]
15. Reforming Canada's Access to Medicines Regime.
Elliott R
CMAJ; 2007 Jul; 177(3):270-1. PubMed ID: 17664453
[No Abstract] [Full Text] [Related]
16. Academic patents and access to medicines in developing countries.
Sampat BN
Am J Public Health; 2009 Jan; 99(1):9-17. PubMed ID: 19008514
[TBL] [Abstract][Full Text] [Related]
17. Intellectual property rights, the World Trade Organization and public health: the Brazilian perspective.
Viana JM
Conn J Int Law; 2002; 17(2):311-8. PubMed ID: 12688298
[No Abstract] [Full Text] [Related]
18. Access for the terminally ill to experimental medical innovations: a three-pronged threat.
Bender S; Flicker L; Rhodes R
Am J Bioeth; 2007 Oct; 7(10):3-6. PubMed ID: 17926208
[No Abstract] [Full Text] [Related]
19. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
20. Gene patents: the need for bioethics scrutiny and legal change.
Andrews LB; Paradise J
Yale J Health Policy Law Ethics; 2005; 5(1):403-12. PubMed ID: 15742584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
